| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/08/2004 | EP1453855A1 Antimicrobial bolisin peptides |
| 09/08/2004 | EP1453539A2 Immunotherapeutic methods and systems |
| 09/08/2004 | EP1207896A4 Methods and compositions for reducing serum phosphate levels |
| 09/08/2004 | EP1180121B9 Long lasting insulinotropic peptides |
| 09/08/2004 | CN1527839A Modified human brain-derived neutrophic factor (BDNF) with reduced immunogenicity |
| 09/08/2004 | CN1527727A Improved chelator conjugates |
| 09/08/2004 | CN1527720A Global analysis of protein activities using proteome chips |
| 09/08/2004 | CN1526725A Antitumor polypeptide and its application |
| 09/08/2004 | CN1165547C Novel lantibiotic related to actagardine, and process for preparation and use thereof |
| 09/08/2004 | CN1165336C Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 09/07/2004 | US6787521 Skin disorders; kidney and liver disorders |
| 09/07/2004 | US6787520 Inactivating process for lipid envelopped virus, and new antivirus lipopeptides |
| 09/07/2004 | US6787329 Comprises two fluorescence dye groups bound to a flexible peptide; self quenching |
| 09/07/2004 | US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof |
| 09/07/2004 | CA2421321A1 Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritis |
| 09/02/2004 | WO2004074479A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom |
| 09/02/2004 | WO2004074316A1 Conformationally constrained backbone cyclized peptide analogs |
| 09/02/2004 | WO2004074312A2 Tryptophyllin peptides and uses thereof |
| 09/02/2004 | WO2004073650A2 Peptidomimetic inhibitors of stat3 activity and their medical uses |
| 09/02/2004 | WO2004073649A2 Clk-peptide and slk-peptide |
| 09/02/2004 | WO2004073640A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 09/02/2004 | WO2004073625A2 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
| 09/02/2004 | WO2004022657A3 Increasing of the resorption of substances via skin and mucous membranes |
| 09/02/2004 | WO2003070967A3 Highly homogeneous molecular markers for electrophoresis |
| 09/02/2004 | WO2003063910A3 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER |
| 09/02/2004 | WO2002072766A8 Induction of tumor immunity by variants of folate binding protein |
| 09/02/2004 | US20040171825 Human fibroblast growth factor-related compositions |
| 09/02/2004 | US20040171795 capable of binding to a gene and transferring this gene into cells, have an affinity with phosphatidylserine, have a high safety and an excellent selectivity; for gene therapy/cancer treatment; genetic engineering |
| 09/02/2004 | US20040171793 Cyclic peptides as potent and selective melanocortin-4 receptors agonists |
| 09/02/2004 | US20040171554 Compositions and methods for enhancing apoptosis |
| 09/02/2004 | US20040171552 for treating a condition involving abnormal cell migration in a subject |
| 09/02/2004 | US20040171530 Polypeptides containing cysteine and tryptophan |
| 09/02/2004 | US20040171520 Melanocortin receptor-specific peptidomimetics |
| 09/02/2004 | US20040171090 Screening for cytotoxic t-lymphocyte recognition antigen associated with human t-cell leukemia virus infected cells for diagnosing and prognosing inflammation and cell proliferation disorders |
| 09/02/2004 | US20040171066 Template-fixed peptidomimetics with antimicrobial activity |
| 09/02/2004 | US20040170955 Human and mouse targeting peptides identified by phage display |
| 09/02/2004 | US20040170653 recognised by CD8-positive cytotoxic T-lymphocytes as a peptide antigen and causes a CTL-induced lysis and/or apoptosis of tumor or leukemia cell; has the amino acid sequence LLGDLFGV, which corresponds to the amino acid positions 81 to 88 of the hdm2 proto-oncoprotein |
| 09/02/2004 | CA2714863A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom |
| 09/02/2004 | CA2516685A1 Peptidomimetic inhibitors of stat3 activity and their medical uses |
| 09/02/2004 | CA2516284A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom |
| 09/02/2004 | CA2516282A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 09/02/2004 | CA2516080A1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
| 09/02/2004 | CA2515033A1 Clk-peptide and slk-peptide |
| 09/01/2004 | EP1452543A2 RGD (ARG-GLY-ASP) coupled to (neuro)peptides |
| 09/01/2004 | EP1452538A1 Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto |
| 09/01/2004 | EP1452182A1 Angiogenesis drugs |
| 09/01/2004 | EP1451590A2 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 09/01/2004 | EP1451220A2 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 09/01/2004 | EP1451210A2 Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451209A2 Tetra-,penta-,hexa- and heptapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451207A2 Labeling reagent and methods of use |
| 09/01/2004 | EP1451201A2 Nucleotide analogues and their use for nucleic acid sequencing |
| 09/01/2004 | EP1450857A2 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 09/01/2004 | EP1450846A2 Self-assembling polymers, and materials fabricated therefrom |
| 09/01/2004 | EP1450843A2 Use of thymulin-like peptides for making pain-relieving medicines |
| 09/01/2004 | EP1450841A2 Tri-, tetra-, and penta-peptides having antiangiogenic activity |
| 09/01/2004 | EP1115738A4 Synthesis of cyclic peptides |
| 09/01/2004 | EP0906336B1 Antibiotic producing microbe |
| 09/01/2004 | CN1526261A Mounting arrangement for auxiliary burner or lance |
| 09/01/2004 | CN1526016A Method for stabilization of nucleic acids |
| 09/01/2004 | CN1525979A Bridged bicyclic serine protease inhibitors |
| 09/01/2004 | CN1525864A Mucin peptide with immunoenhancing properties |
| 09/01/2004 | CN1524873A Method of manufacturing t-20 and t-1249 peptides at commercial scale, and t-20 and t-1249 compositions related thereto |
| 09/01/2004 | CN1164334C Sustained release formulation of peptide |
| 08/31/2004 | US6784283 Peptide antibiotics |
| 08/31/2004 | US6784156 Cyclosporins for the treatment of respiratory diseases |
| 08/31/2004 | US6784155 Contacting hematopoietic cells with a stem cell proliferation stimulating amount of inprol or an opiate compound or a combination of inprol and an opiate compound |
| 08/31/2004 | US6784153 Identify molecules that can bind to organ or tissue specific markers and, therefore, can home to the organ or tissue; membrane dipeptidase (mdp)-binding homing molecule, which is a molecule that selectively homes to lung endothelium |
| 08/31/2004 | US6783958 Generating biosensor protein; determine sequence of fluorescent protein, generate fusion protein, incubate with modulator, detect conformational adjustments, monitor adjustments in fluorescence |
| 08/31/2004 | US6783761 Hormone inhibitors for inducing antibodies against gonadotropin-releasing hormone, comprises fusion peptide of helper t-cell peptide epitope and immunomimic peptide epitope |
| 08/26/2004 | WO2004072108A1 Cyclosporins for the treatment of immune disorders |
| 08/26/2004 | WO2004072106A1 Method of eliminating phosphate group of peptide and method of analyzing peptide |
| 08/26/2004 | WO2004072095A2 Cyclized peptides as exotoxin antagonists |
| 08/26/2004 | WO2004071457A2 Improved heat shock protein-based vaccines and immunotherapies |
| 08/26/2004 | WO2004035735A3 A structured peptide scaffold for displaying turn libraries on phage |
| 08/26/2004 | WO2004035609A3 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions. |
| 08/26/2004 | WO2004030687A8 Long-acting gonadotropin-releasing hormone analogs and methods of use thereof |
| 08/26/2004 | WO2004018706A3 A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 08/26/2004 | WO2004011599A3 Polypeptide cleavage process |
| 08/26/2004 | WO2003102544A3 Assays for measuring matrix metalloproteinase activities |
| 08/26/2004 | WO2003095475A3 Peptide compounds and their use as protease substrates |
| 08/26/2004 | WO2002102320A3 Fce fusion proteins for treatment of allergy and asthma |
| 08/26/2004 | US20040167201 Pyrrolidine melanocortin-specific compounds |
| 08/26/2004 | US20040167191 Glutaminyl based DPIV inhibitors |
| 08/26/2004 | US20040167072 Inhibitors of receptor activator of NF-kappaB and uses thereof |
| 08/26/2004 | US20040167060 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 08/26/2004 | US20040166118 Immunocastration of pigs |
| 08/26/2004 | US20040166059 conjugates of a residue of vitamin B12 and a residue of a peptide or an amino acid comprising a radionuclide that are useful to image tumors |
| 08/26/2004 | CA2520591A1 Improved heat shock protein-based vaccines and immunotherapies |
| 08/25/2004 | EP1448602A2 Modified anti-tnf alpha antibody |
| 08/25/2004 | EP1448218A2 Beta-secretase inhibitors and methods of use |
| 08/25/2004 | CN1524090A Modified insulin with reduced immunogenicity |
| 08/25/2004 | CN1523996A Methods for reducing immunogenicity of polypeptides |
| 08/25/2004 | CN1163599C Anti-GPIIB/IIIA recombination antibody |
| 08/25/2004 | CN1163505C Anticancer polypeptide |
| 08/25/2004 | CN1163504C Process for preparing resin-bound cyclic peptide |
| 08/25/2004 | CN1163260C Ionic molecular conjugates of biodergaable polyesters and bioactive polypeptides |
| 08/25/2004 | CA2457389A1 Method of manufacturing t-20 and t-1249 peptides at commercial scale, and t-20 and t-1249 compositions related thereto |
| 08/24/2004 | US6780972 Reacting an acid addition salt of a basic starting peptide in the presence of a diluent in a mixed bed ion exchanger; forming a free peptide; and then forming the desired acid addition salt of the peptide |
| 08/24/2004 | US6780971 Compositions for inhibiting the aggregation pathway of α-synuclein |